AdipoGen Life Sciences InVivoKines recombinant fusion proteins

Thursday, 11 December, 2025 | Supplied by: Sapphire Bioscience


InVivoKines are recombinant fusion proteins for immunotherapeutic, preclinical and translational in vivo research, developed in-house by AdipoGen Life Sciences. The company has leveraged knobs-into-holes (KIH) technology to develop monomeric, heterodimeric or homodimeric Fc fusion proteins.

Features include: native conformation (production in HEK 293 or CHO cells); production under animal-free conditions; high bioactivity tested by ELISA/cell-based assays; verified purity and homogeneity by SEC; low endotoxin levels; and batch-to-batch consistency.

InVivoKines are distributed in Australia and New Zealand by Sapphire Bioscience.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Terumo K-Pack Embrace active safety needle

The K-Pack Embrace active safety needle is packaged in a rigid cap and case container, designed...

Scientifica PatchPad Evo electrophysiology controller

Scientifica introduces PatchPad Evo, a next-generation electrophysiology controller that provides...

AdipoGen Cystatin C (mouse) (monomer):Fc (silent) InVivoKine fusion proteins

InVivoKines are a new generation of recombinant fusion proteins for immunotherapeutic,...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd